Search

everythinglearnresearchcommunity

for

Search:↓

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Women with PCOS often feel stigmatized and have mood issues, which can lower their sexual satisfaction, but proper treatment and support can help.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

No cure for female pattern hair loss, but various effective treatments exist.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Hair growth is influenced by interactions between skin layers, growth factors, and hormones, but the exact mechanisms are not fully understood.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

Dutasteride-containing mesotherapy effectively treats female hair loss, improving density and thickness with minimal side effects.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

Treat genetic hair loss early with FDA-approved medications and consider hair transplantation.

The study found that women with PCOS have more and larger ovarian follicles and differences in ovarian structure, but these features alone can't always diagnose PCOS.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Minoxidil effectively treats female pattern hair loss.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Young women with high male hormone levels or PCOS often feel more psychological distress and have a lower quality of life.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.